AU2002306413A1 - Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections - Google Patents

Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections

Info

Publication number
AU2002306413A1
AU2002306413A1 AU2002306413A AU2002306413A AU2002306413A1 AU 2002306413 A1 AU2002306413 A1 AU 2002306413A1 AU 2002306413 A AU2002306413 A AU 2002306413A AU 2002306413 A AU2002306413 A AU 2002306413A AU 2002306413 A1 AU2002306413 A1 AU 2002306413A1
Authority
AU
Australia
Prior art keywords
pyrido
treatment
human cytomegalovirus
cytomegalovirus infections
pyrimidin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002306413A
Inventor
Douglas Wayne Balogh
Joseph Matthew Colacino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002306413A1 publication Critical patent/AU2002306413A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
AU2002306413A 2001-02-16 2002-02-04 Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections Abandoned AU2002306413A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26948701P 2001-02-16 2001-02-16
US60/269,487 2001-02-16
PCT/US2002/001232 WO2002078709A2 (en) 2001-02-16 2002-02-04 Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections

Publications (1)

Publication Number Publication Date
AU2002306413A1 true AU2002306413A1 (en) 2002-10-15

Family

ID=23027461

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002306413A Abandoned AU2002306413A1 (en) 2001-02-16 2002-02-04 Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections

Country Status (2)

Country Link
AU (1) AU2002306413A1 (en)
WO (1) WO2002078709A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4882334A (en) * 1988-05-25 1989-11-21 The Trustees Of Princeton University N-(5,6,7,8-tetrahydropyrido]2,3-d]pyrimidin-6-ylethl-thineyl-and furylcarbonyl)-glutamic acid derivatives
US5594139A (en) * 1993-01-29 1997-01-14 Agouron Pharmaceuticals, Inc. Processes for preparing antiproliferative garft-inhibiting compounds
US5608082A (en) * 1994-07-28 1997-03-04 Agouron Pharmaceuticals, Inc. Compounds useful as antiproliferative agents and GARFT inhibitors

Also Published As

Publication number Publication date
WO2002078709A2 (en) 2002-10-10
WO2002078709A3 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
AU2001291893A1 (en) Use of substituted imidazo(1,2-a)pyridine-, imidazo(1,2-a)pyrimidine and imidazo(1,2-a)pyrazine-3-yl-amine derivatives for producing NOS-inhibiting medicaments
EP1416935B8 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
AP2002002456A0 (en) Pyrazolo '4,3-d pyrimidine derivatives
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HK1062300A1 (en) 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d)pyrimidine derivatives
AU2002310768A1 (en) Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
HK1064669A1 (en) Substituted 1-oxy-2,8-diaza-spiro Ä4,5Üdec-2-ene derivatives as medicaments for the treatment of pain.
AU2002352142A1 (en) Pyrazolopyridine derivatives
IL160402A0 (en) Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido {1,2-a} pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-pyrimidin-5 (1h) one derivatives
AU2002361407A1 (en) Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
IL187900A0 (en) Derivatives of pyrido[2,3-d] pyrimidine, the preparation thereof, and the therapeutic application of the same
AU2003224760A1 (en) Process for the preparation of antiviral 7-azaindole derivatives
MXPA03008965A (en) Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments.
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU2001279958A1 (en) Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders
AP2329A (en) 2-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2,3-d] pyrimidin-4 - one derivatives, the preparation and the pharmaceutical use thereof.
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
AU2002359160A1 (en) PIPAZOLO (1,5-a) PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR
MXPA03008894A (en) Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments.
AU2002349013A1 (en) Use of 7h-pyrrolo(2,3-d)pyrimidine derivatives in the treatment of solid tumor diseases
AU2002216033A1 (en) Use of pyrazolo(4,3-d)pyrimidines
AU2002306413A1 (en) Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections
SI1458721T1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino (4,5-b)indole-1-carboxamide derivatives, their preparation and therapeutic use
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AU2002338794A1 (en) Use of mannosamine derivatives for the stimulation of neurite growth

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase